Vertex Pharmaceuticals
VRTX
#158
Rank
NZ$186.71 B
Marketcap
$725.02
Share price
0.33%
Change (1 day)
8.56%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2024 (TTM): NZ$0.38 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are NZ$10.62 Billion. In 2023 the company made an earning of NZ$7.87 Billion, an increase over its 2022 earnings that were of NZ$7.63 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.38 B-95.16%
2023 NZ$7.87 B3.19%
2022 NZ$7.63 B53.56%
2021 NZ$4.97 B-12.06%
2020 NZ$5.65 B118.45%
2019 NZ$2.58 B120.64%
2018 NZ$1.17 B1473.64%
2017 NZ$74.55 M197.6%
2016 NZ$25.05 M-102.97%
2015 -NZ$0.85 Billion-28.46%
2014 -NZ$1.18 Billion-51.5%
2013 -NZ$2.44 Billion-30584.68%
2012 NZ$7.97 M-95.47%
2011 NZ$0.17 B
2009 -NZ$1.06 Billion
2007 -NZ$0.74 Billion83.1%
2006 -NZ$0.41 Billion59.02%
2005 -NZ$0.26 Billion3.28%
2004 -NZ$0.25 Billion-38.16%
2003 -NZ$0.4 Billion
2000 -NZ$67.75 Million-20.38%
1999 -NZ$85.09 Million31.62%
1998 -NZ$64.65 Million91.05%
1997 -NZ$33.84 Million-36.24%
1996 -NZ$53.08 Million12.45%
1995 -NZ$47.2 Million27.4%
1994 -NZ$37.05 Million-1833.33%
1993 NZ$2.13 M-112.12%
1992 -NZ$17.64 Million175%
1991 -NZ$6.42 Million-12.2%
1990 -NZ$7.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$0.31 B-40.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.81 B 2,315.10%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$26.66 B 4,924.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$12.26 Billion-2,408.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.75 B 6,072.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.2 Billion-135.86%๐Ÿ‡บ๐Ÿ‡ธ USA